Promoting education, mentorship, and support for pediatric research

    Pediatrics
    |April 30, 2014
    PubMed

    Insights

    Pediatricians are vital for advancing child health research. Enhancing research education and support is crucial for improving children's physical, mental, and social well-being through evidence-based practices.

    Area of Science:

    • Pediatric Health Research
    • Child Well-being Studies
    • Evidence-Based Pediatrics

    Background:

    • Pediatricians are essential for advancing child health research, addressing unique physical, mental, and social well-being challenges.
    • The pediatric research scope is transdisciplinary, encompassing basic, translational, community, health services, and policy research.

    Purpose of the Study:

    • To emphasize the critical role of pediatricians in child health research.
    • To recommend strategies for enhancing research education and support across all training levels.
    • To advocate for increased mentorship and reduced barriers for pediatric researchers.

    Main Methods:

    • This statement outlines recommendations for pediatric research education and support.
    • It addresses training from premedical through continuing medical education.
    • It focuses on mentorship and reducing barriers for research participation.

    Main Results:

    • Knowledge of research methodologies enhances critical evaluation of literature and evidence-based practice.
    • Improved research education and support are recommended for pediatric trainees, practitioners, and faculty.
    • Facilitating new knowledge creation is a key goal for the American Academy of Pediatrics.

    Conclusions:

    • Pediatric research is fundamental to the American Academy of Pediatrics' mission to improve child health.
    • Strengthening research education, support, and mentorship is vital for pediatricians.
    • Overcoming barriers is necessary to foster a robust pediatric research enterprise.

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    410
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    408
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    554
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    967
    The Retinoblastoma Gene01:20

    The Retinoblastoma Gene

    2.1K